Daily oral GLP-1 pill a promising alternative to injectables for weight loss, clinical trial finds
A new oral GLP-1 medication can help adults with obesity and type 2 diabetes lose more weight and improve their blood sugar levels compared to a placebo, according to findings from the ATTAIN-2 trial led by a UTHealth Houston researcher.
Can Novo unravel Lilly rally with Alzheimer’s data for GLP-1 – Seeking Alpha
Can Novo unravel Lilly rally with Alzheimer’s data for GLP-1 Seeking Alpha High-stakes Novo Nordisk Alzheimer’s studies could yield answers on GLP-1 benefit Reuters Can GLP-1 drugs treat Alzheimer’s? Novo Nordisk will soon announce key results statnews.com Key facts: Novo Nordisk trials Rybelsus for cognitive decline; analysts see stable growth TradingView Novo Nordisk Will Soon Reveal Whether Its GLP-1 […]
Novo Launches Studies to See Whether GLP-1 Drugs Can Slow Alzheimer’s
Post Content
GLP-1 Market Incentives, Pharma Partnerships, and AI Restrictions:
A Consolidated Overview Continue reading on Penny Press »
Novo Nordisk Just Took a Big Swing, Slashing Its GLP-1 Drug Prices. Will It Pay Off for the Healthcare Giant?
Over the past several years, GLP-1 agonist weight-loss drugs have evolved from a celebrity trend to arguably the hottest growth opportunity in the pharmaceutical industry. Novo Nordisk (NYSE: NVO) jumped out to an early lead with the immense popularity of its Ozempic and Wegovy (semaglutide), used to treat type 2 diabetes and obesity. However, a […]
Biology, Vol. 14, Pages 1650: GLP-1 Receptor Signaling and Oral Dysfunction: A Narrative Review on the Mechanistic Basis of Semaglutide-Related Oral Adverse Effects
Biology, Vol. 14, Pages 1650: GLP-1 Receptor Signaling and Oral Dysfunction: A Narrative Review on the Mechanistic Basis of Semaglutide-Related Oral Adverse Effects Biology doi: 10.3390/biology14121650 Authors: Milena Barać Jelena Roganović This review addresses the growing concern of oral side effects, particularly dry mouth, associated with semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1RA) widely used […]
Nutrients, Vol. 17, Pages 3659: Macronutrient, Micronutrient Supplementation and Monitoring for Patients on GLP-1 Agonists: Can We Learn from Metabolic and Bariatric Surgery?
Nutrients, Vol. 17, Pages 3659: Macronutrient, Micronutrient Supplementation and Monitoring for Patients on GLP-1 Agonists: Can We Learn from Metabolic and Bariatric Surgery? Nutrients doi: 10.3390/nu17233659 Authors: Rhea Sibal G. Balamurugan Jasmine Langley Yitka Graham Kamal Mahawar Background/Objectives: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are increasingly prescribed for people living with obesity and type 2 diabetes […]
Eli Lilly Hits $1 Trillion Milestone on GLP-1 Boom
Eli Lilly Hits $1 Trillion Milestone on GLP-1 Boom Eli Lilly and Company BATS:LLY DEXWireNews Eli Lilly & Co. (NYSE: LLY ) briefly crossed the $1 trillion market-cap threshold, becoming the first health-care company in history to reach the valuation. Shares traded around $1,059 as demand for its GLP-1 weight-loss and diabetes drugs exploded, driving […]
Managing weight
The Ozempic era should change how we think about self-control Oh, oh, oh, Ozempic! The catchy jingle from Novo Nordisk’s 2018 TV commercial helped to popularise Ozempic and cement its name as a generic term for an entire category of drugs, now prescribed to millions of people to treat diabetes and obesity. An earworm, however, […]
Integrative gene-metabolite network analysis of GLP-1 receptor agonists and related incretin pathways in cardiometabolic health
Post Content